TESTICULAR CANCER
Clinical trials for TESTICULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new TESTICULAR CANCER trials appear
Sign up with your email to follow new studies for TESTICULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat HER2 cancers: drug shows promise in real-world study
Disease control Recruiting nowThis study looks at how well the drug T-DXd works in adults with advanced HER2-positive solid tumors that have spread and are not responding to other treatments. About 100 people will be followed to see if their tumors shrink and how long that lasts. The goal is to provide a trea…
Matched conditions: TESTICULAR CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
New drug tested for hard-to-treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called GV20-0251 in people with advanced solid tumors that no longer respond to standard treatments. The main goal is to check the drug's safety. About 10 adults with cancers like liver, lung, or skin cancer will take part. This is not a cu…
Matched conditions: TESTICULAR CANCER
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New antibody therapy targets hard-to-treat ovarian cancer
Disease control Recruiting nowThis early-phase study tests a new drug called CTIM-76 in people with ovarian, testicular, or endometrial cancer that has come back or stopped responding to standard treatments. The drug works by helping the immune system attack cancer cells that have a specific marker called CLD…
Matched conditions: TESTICULAR CANCER
Phase: PHASE1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Radiation plus targeted drug shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests whether adding a drug called tarlatamab to standard radiation therapy is safe and effective for cancers that have a protein called DLL3, such as certain lung cancers, melanomas, and bladder cancers. About 30 adults with advanced or returning cancers will receive …
Matched conditions: TESTICULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Aspirin may shield cancer patients from deadly clots
Prevention Recruiting nowThis study tests whether a daily low-dose aspirin can prevent dangerous blood clots in people with advanced germ cell cancer (including testicular cancer) who are receiving standard chemotherapy. About 35 participants at high risk for clots will take aspirin alongside their chemo…
Matched conditions: TESTICULAR CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated May 05, 2026 11:53 UTC
-
New app aims to ease young cancer Survivors' pain and stress
Symptom relief Recruiting nowThis study is testing a digital health program called AYA STEPS for adolescent and young adult cancer survivors. The program helps manage common symptoms like pain, fatigue, and emotional distress, and encourages participants to stay engaged with their follow-up medical care. Abo…
Matched conditions: TESTICULAR CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 16, 2026 22:29 UTC
-
Which painkiller wins? new study tests two options after cancer surgery
Symptom relief Recruiting nowThis study compares two standard pain relief methods—morphine given via a spinal injection and methadone given through an IV—for men undergoing testicular cancer surgery. The goal is to see which provides better pain control and reduces the need for additional opioids. About 142 …
Matched conditions: TESTICULAR CANCER
Phase: PHASE3 • Sponsor: Indiana University • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Testicular cancer surgery: which technique hurts less?
Symptom relief Recruiting nowThis study looks at two common ways to remove a testicle affected by cancer. The goal is to find out if one method causes less pain and requires fewer painkillers after surgery. About 80 adults with testicular cancer will take part, and they will report their pain levels and reco…
Matched conditions: TESTICULAR CANCER
Phase: NA • Sponsor: Loma Linda University • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Testicular cancer study: which treatment spares quality of life?
Knowledge-focused Recruiting nowThis study follows 160 men with good prognosis metastatic testicular cancer to see if surgery (RPLND) causes fewer side effects than chemotherapy. Participants choose or are assigned to either surgery or 3-4 rounds of chemo. Researchers track quality of life, fatigue, and other o…
Matched conditions: TESTICULAR CANCER
Phase: NA • Sponsor: Sahlgrenska University Hospital • Aim: Knowledge-focused
Last updated May 16, 2026 22:27 UTC
-
AI could revolutionize how cancer patients find clinical trials
Knowledge-focused Recruiting nowThis study is testing whether an artificial intelligence (AI) tool can help match people with advanced cancer to the right clinical trials. Researchers will enroll up to 50,000 participants to see if the AI improves trial enrollment rates and patient outcomes. The goal is to make…
Matched conditions: TESTICULAR CANCER
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Massive cancer registry aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study is creating a large database of medical information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. The goal is to help researchers better understand what causes cancer, how it progresses, and how to improve p…
Matched conditions: TESTICULAR CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC